Management of Coronary Artery Diseases in Systemic Vasculitides: Complications and Strategies.

cardiovascular complications coronary artery bypass grafting coronary artery disease immunosuppressive therapy percutaneous coronary intervention personalized medicine systemic vasculitides

Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
25 Sep 2024
Historique:
received: 01 08 2024
revised: 13 09 2024
accepted: 20 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Coronary artery disease (CAD) presents a significant risk for patients with systemic vasculitides, a group of disorders characterized by the inflammation of blood vessels. In this review, we focus on the pathophysiological mechanisms, complications, and management strategies for CAD in systemic vasculitides. We highlight how the inflammatory processes inherent in vasculitis contribute to accelerated atherosclerosis and myocardial ischemia. Key strategies in managing CAD in this patient population include using medicine treatments to mitigate vascular inflammation while balancing the risk of promoting cardiovascular events and lifestyle modifications. Understanding the nuanced relationship between systemic vasculitides and CAD is crucial for improving patient outcomes and guiding therapeutic approaches.

Identifiants

pubmed: 39459361
pii: medicina60101574
doi: 10.3390/medicina60101574
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : This study is financed by the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
ID : project No BG-RRP-2.004-0008

Auteurs

Russka Shumnalieva (R)

Department of Rheumatology, Clinic of Rheumatology, University Hospital St. Ivan Rilski, Urvich Str. 13, 1612 Sofia, Bulgaria.
Faculty of Medicine, Medical University of Sofia, Urvich Str. 13, 1612 Sofia, Bulgaria.
Medical Faculty, Sofia University, St. Kliment Ohridski, 1 Kozyak Str., 1407 Sofia, Bulgaria.

Niya Mileva (N)

Cardiology Department, SHATC Medica Cor, Riga Str. 35, 7013 Ruse, Bulgaria.

Ivan Padjen (I)

Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, University of Zagreb, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.

Periklis Siliogkas (P)

General Hospital of Athens Korgialeneio-Benakeio Hellenic Red Cross, Athanasaki 11, 11526 Athens, Greece.

Lyubomir Chervenkov (L)

Department of Diagnostic Imaging, Medical University Plovdiv, Bul. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.
Research Complex for Translational Neuroscience, Medical University of Plovdiv, Bul. Vasil Aprilov 15A, 4002 Plovdiv, Bulgaria.

Konstantina Bakopoulou (K)

Faculty of Medicine, Medical University Sofia, Boulevard 'Akademik Ivan Evstratiev Geshov' 15, 1431 Sofia, Bulgaria.

Issa El Kaouri (IE)

Faculty of Medicine, Medical University Sofia, Boulevard 'Akademik Ivan Evstratiev Geshov' 15, 1431 Sofia, Bulgaria.

Anna Vasilska (A)

Department of Diagnostic Imaging, Medical University Plovdiv, Bul. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.

Dimitrina Miteva (D)

Medical Faculty, Sofia University, St. Kliment Ohridski, 1 Kozyak Str., 1407 Sofia, Bulgaria.
Department of Genetics, Faculty of Biology, Sofia University "St. Kliment Ohridski", 8 Dragan Tzankov Str., 1164 Sofia, Bulgaria.

Dobrin Vassilev (D)

Ruse University Angel Kanchev, ul. "Studentska" 8, 7017 Ruse, Bulgaria.

Tsvetelina Velikova (T)

Medical Faculty, Sofia University, St. Kliment Ohridski, 1 Kozyak Str., 1407 Sofia, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH